A retrospective study assessing the effect on kidney function during a 24-month period in HIV-positive patients who were on combined antiretroviral therapy
Latest Information Update: 28 Jun 2021
At a glance
- Drugs Abacavir/dolutegravir/lamivudine (Primary) ; Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary) ; Dolutegravir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Raltegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 28 Jun 2021 New trial record
- 16 Jun 2021 Results published in the International Journal of Clinical Practice